It was reported that TFPI2 can regulate the endothelial–mesenchymal transition and the TGF-β2 signaling pathway and is a potential promoter of DKD pathogenesis (Guan et al., 2022). This evidence concerns the gene TFPI2 and diabetic kidney disease.